Summary

Global Pathology Laboratories Market is valued at approximately USD 311.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.86% over the forecast period 2022-2029. A pathology laboratory is a place where medical tests are performed on clinical specimens to learn more about a patient's health and to help with illness diagnosis, treatment, and prevention. The rising emphasis on advancing the healthcare infrastructure in underdeveloped and developing countries, high reimbursement for diagnostics services, and increasing prevalence of various chronic diseases are primary factors that are stipulating the market growth around the world.

The growing need for regular general health check-ups among the senior population is acting as a catalyzing factor for market growth globally. According to the World Health Organization (WHO), it was expected that the number of ageing people increases from 1 billion in 2020 to 1.5 billion in 2030 that worldwide accounting for 1 in 6 people above 60. Accordingly, the incidences of chronic disorders are more prevalent in geriatric people. The national council reported that in the U.S the ageing 80% of adults above the age of 65 are affected by at least one chronic disease, which is witnessing rising needs for medical check-ups for the geriatric age group. Thereby, these aforementioned factors are surging the growth of the market. Moreover, the rising technological advancements, as well as the growing healthcare spending are presenting various lucrative opportunities over the forecasting years. However, the huge capital required for high-end molecular diagnostics and the dearth of skilled professionals are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pathology Laboratories Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing awareness regarding healthcare and the rising incidence of various target diseases. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as the availability of cost-effective pathology tests, increasing expenditure on healthcare, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:
Healius Limited
Quest Diagnostics Incorporated
Eurofins Scientific
Laboratory Corporation of America Holdings
Exact Sciences Laboratories LLC
Spectra Laboratories Incorporated
SYNLAB International GmbH
Sonic Healthcare Limited
Dr. Lal Path Labs
Metropolis Healthcare Limited

Recent Developments in the Market:
 In January 2022, Quest Diagnostics announced the acquisition of Pack Health- a patient engagement company. The aim of this acquisition is to improve value-based service.
 In May 2021, Quest Diagnostics declared that the company collaborated with Paige with the objective of enhancing the quality of oncology testing by using the advancement in AI-generated pathology.


Global Pathology Laboratories Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Testing Services, End-use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Hospital-based
Standalone Labs
Diagnostic Chains
By Testing Services:
General Physiological & Clinical Tests
Imaging & Radiology Tests
Esoteric Tests
COVID-19 Tests
By End-use:
Physician Referrals
Walk-ins
Corporate
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Pathology Laboratories Market, by Region, 2019-2029 (USD Billion)
1.2.2. Pathology Laboratories Market, by Type, 2019-2029 (USD Billion)
1.2.3. Pathology Laboratories Market, by Testing Services, 2019-2029 (USD Billion)
1.2.4. Pathology Laboratories Market, by End-use, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Pathology Laboratories Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Pathology Laboratories Market Dynamics
3.1. Pathology Laboratories Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising emphasis on the advancing healthcare infrastructure
3.1.1.2. Growing need for regular general health check-ups among the senior population
3.1.2. Market Challenges
3.1.2.1. Huge capital is required for high-end molecular diagnostics
3.1.2.2. Dearth of skilled professionals
3.1.3. Market Opportunities
3.1.3.1. Rising technological advancements
3.1.3.2. Growing healthcare spending
Chapter 4. Global Pathology Laboratories Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Pathology Laboratories Market, by Type
6.1. Market Snapshot
6.2. Global Pathology Laboratories Market by Type, Performance - Potential Analysis
6.3. Global Pathology Laboratories Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Pathology Laboratories Market, Sub Segment Analysis
6.4.1. Hospital-based
6.4.2. Standalone Labs
6.4.3. Diagnostic Chains
Chapter 7. Global Pathology Laboratories Market, by Testing Services
7.1. Market Snapshot
7.2. Global Pathology Laboratories Market by Testing Services, Performance - Potential Analysis
7.3. Global Pathology Laboratories Market Estimates & Forecasts by Testing Services 2019-2029 (USD Billion)
7.4. Pathology Laboratories Market, Sub Segment Analysis
7.4.1. General Physiological & Clinical Tests
7.4.2. Imaging & Radiology Tests
7.4.3. Esoteric Tests
7.4.4. COVID-19 Tests
Chapter 8. Global Pathology Laboratories Market, by End-use
8.1. Market Snapshot
8.2. Global Pathology Laboratories Market by End-use, Performance - Potential Analysis
8.3. Global Pathology Laboratories Market Estimates & Forecasts by End-use 2019-2029 (USD Billion)
8.4. Pathology Laboratories Market, Sub Segment Analysis
8.4.1. Physician Referrals
8.4.2. Walk-ins
8.4.3. Corporate
Chapter 9. Global Pathology Laboratories Market, Regional Analysis
9.1. Pathology Laboratories Market, Regional Market Snapshot
9.2. North America Pathology Laboratories Market
9.2.1. U.S. Pathology Laboratories Market
9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Testing Services breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-use breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Pathology Laboratories Market
9.3. Europe Pathology Laboratories Market Snapshot
9.3.1. U.K. Pathology Laboratories Market
9.3.2. Germany Pathology Laboratories Market
9.3.3. France Pathology Laboratories Market
9.3.4. Spain Pathology Laboratories Market
9.3.5. Italy Pathology Laboratories Market
9.3.6. Rest of Europe Pathology Laboratories Market
9.4. Asia-Pacific Pathology Laboratories Market Snapshot
9.4.1. China Pathology Laboratories Market
9.4.2. India Pathology Laboratories Market
9.4.3. Japan Pathology Laboratories Market
9.4.4. Australia Pathology Laboratories Market
9.4.5. South Korea Pathology Laboratories Market
9.4.6. Rest of Asia Pacific Pathology Laboratories Market
9.5. Latin America Pathology Laboratories Market Snapshot
9.5.1. Brazil Pathology Laboratories Market
9.5.2. Mexico Pathology Laboratories Market
9.5.3. Rest of Latin America Pathology Laboratories Market
9.6. Rest of The World Pathology Laboratories Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Healius Limited
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Quest Diagnostics Incorporated
10.2.3. Eurofins Scientific
10.2.4. Laboratory Corporation of America Holdings
10.2.5. Exact Sciences Laboratories LLC
10.2.6. Spectra Laboratories Incorporated
10.2.7. SYNLAB International GmbH
10.2.8. Sonic Healthcare Limited
10.2.9. Dr. Lal Path Labs
10.2.10. Metropolis Healthcare Limited
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption